We conclude from our data that cfDNA of AAA patients triggers a proinflammatory response in macrophages by activating the AIM2 inflammasome and thus could be a driving force for the chronic inflammation observed in these patients. The gene discussed is AIM2; the disease is triple-A syndrome.